*Actual vial appearance, contents, and dosage may vary and is based on your prescription.
Low-dose methylene blue has been studied for its role as a redox agent that supports mitochondrial electron transport and ATP production efficiency in cellular models.
https://pubmed.ncbi.nlm.nih.gov/20373365/
Research has evaluated methylene blue for effects on memory, attention, and brain energy metabolism through mitochondrial and cerebral blood flow mechanisms.
https://pubmed.ncbi.nlm.nih.gov/23540455/
Methylene blue has been studied in preclinical and early human research for mechanisms related to oxidative stress modulation and neuronal resilience.
https://pubmed.ncbi.nlm.nih.gov/22748238/
As a reversible redox compound, methylene blue participates in antioxidant and pro-oxidant signaling pathways depending on dose and context.
https://pubmed.ncbi.nlm.nih.gov/21178457/
Methylene blue appears in longevity-focused research discussions related to mitochondrial efficiency and cellular aging models.
https://pubmed.ncbi.nlm.nih.gov/30301727/
Methylene blue capsules are prescribed by licensed healthcare providers based on an individual clinical evaluation and medical eligibility. Compounded oral formulations are not FDA-approved, and their safety and effectiveness have not been independently evaluated by the FDA.
This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational purposes only and does not constitute medical advice. All care and prescriptions are provided solely at the discretion of a licensed healthcare provider following an individual evaluation.
Below are peer-reviewed studies and authoritative references related to methylene blue:
Atamna H, et al. — Low-dose methylene blue as a mitochondrial enhancer.
Gonzalez-Lima F, et al.
Hear from individuals who chose a more guided, informed approach to their wellness journey.
A Celara Med User
A Celara Med User
Quick answers to common questions, designed to help you feel clear and confident as you explore Celara Med.
In wellness-focused contexts, low-dose methylene blue has been studied for its effects on mitochondrial function, cellular energy metabolism, and redox signaling pathways.
https://pubmed.ncbi.nlm.nih.gov/20373365/
No. Methylene blue is not a stimulant. Its studied effects relate to cellular energy and mitochondrial signaling rather than stimulant pathways.
No. This formulation is oral capsules, not injectable or IV methylene blue.
Adults interested in cognitive performance, energy metabolism, or mitochondrial health may be evaluated by a licensed healthcare provider. Eligibility is determined through individual clinical review.
Yes. Methylene blue may interact with certain medications, particularly SSRIs, SNRIs, MAOIs, and serotonergic drugs, due to monoamine oxidase inhibition at higher doses. This is reviewed carefully during provider evaluation.
https://pubmed.ncbi.nlm.nih.gov/19081209/
Possible effects include headache, nausea, dizziness, gastrointestinal upset, or blue/green discoloration of urine or stool. Side effects vary by individual.
Methylene blue capsules are taken orally as directed by a licensed healthcare provider. Dosing and frequency are individualized.
Methylene blue capsules through Celara Med are available in 48 states, excluding Alabama and Mississippi, subject to state regulations and provider licensure.
Yes. Methylene blue is offered within a structured care plan designed to support appropriate use, monitoring, and clinical oversight.
Explore other provider-guided options that may better align with your goals.
Semax and Selank are synthetic regulatory peptides that have been studied primarily in preclinical models and limited human research